已收盘 08-01 16:00:00 美东时间
-0.700
-5.49%
Wabash National (NYSE:WNC) is gearing up to announce its quarterly earnings on ...
07-25 00:00
Barclays analyst Adam Seiden maintains Manitowoc Co (NYSE:MTW) with a Underweight and raises the price target from $9 to $11.
07-21 21:08
Highlights of the Announced Transaction Combines Two Strong Community Banks. Merges two relationship-driven deposit franchises with deep community roots and a shared commitment to responsive...
07-18 21:00
Divestiture of the Manitowoc, WI facility optimizes asset base and improves operating leverageFurther diversifies BWEN's business toward higher-margin precision manufacturing segmentsSignificantly enhances liquidity,
06-05 15:39
Broadwind Announces Sale of Industrial Fabrication Operations in Manitowoc, Wis...
06-05 07:00
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities:维持Mersana Therapeutics(MRSN)"买入"评级,目标价从9美元升至10美元</p> <p>• Guggenheim:维持Cabaletta Bio(CABA)"买入
05-17 08:44
UBS analyst Steven Fisher maintains Manitowoc Co (NYSE:MTW) with a Neutral and raises the price target from $9 to $11.
05-16 22:48
Baird analyst Mircea Dobre maintains Manitowoc Co (NYSE:MTW) with a Neutral and lowers the price target from $12 to $11.
05-08 21:08
AMMO (NASDAQ:POWW) announced that it finalized the sale of its ammunition manufacturing assets, including its 185,000-square-foot Manitowoc, Wisconsin facility, to Olin Winchester, a subsidiary of Oli...
04-21 18:37
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116650478822592513.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Pacira BioSciences(PCRX)"买入"评级,目标价从48美元升至65美元</p> <p>• 瑞穗:上调Amylyx Pharmaceuticals(AM
04-09 08:50